May T. Htut-Aung

Frome Road
Adelaide, SA 5000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression.

Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression.

Journal: Molecular therapy. Nucleic acids

Published: June 04, 2026

A severe neurodevelopmental syndrome linked to a South Asian founder variant in the UFMylation adaptor CDK5RAP3.

A severe neurodevelopmental syndrome linked to a South Asian founder variant in the UFMylation adaptor CDK5RAP3.

Journal: Acta neuropathologica

Published: March 29, 2026

Impact of mRNA and protein isoforms in lipoprotein metabolism and how to modulate them.

Impact of mRNA and protein isoforms in lipoprotein metabolism and how to modulate them.

Journal: Current opinion in lipidology

Published: February 08, 2026

Overgrowth-intellectual disability disorders: progress in biology, patient advocacy and innovative therapies.

Overgrowth-intellectual disability disorders: progress in biology, patient advocacy and innovative therapies.

Journal: Disease models & mechanisms

Published: May 12, 2025

Discovery of Novel APOC3 Isoforms in Hepatic and Intestinal Cell Models Using Long-Read RNA Sequencing.

Discovery of Novel APOC3 Isoforms in Hepatic and Intestinal Cell Models Using Long-Read RNA Sequencing.

Journal: Genes

Published: March 14, 2025

Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in COL3A1 Exon 10 or 15?

Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in COL3A1 Exon 10 or 15?

Journal: International journal of molecular sciences

Published: July 01, 2024

Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.

Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.

Journal: International journal of molecular sciences

Published: April 18, 2024

Antisense oligonucleotides and their applications in rare neurological diseases.

Antisense oligonucleotides and their applications in rare neurological diseases.

Journal: Frontiers in neuroscience

Published: April 09, 2024

Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions.

Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions.

Journal: Frontiers in molecular neuroscience

Published: February 26, 2024

Induced alternative splicing an opportunity to study PCSK9 protein isoforms at physiologically relevant concentrations.

Induced alternative splicing an opportunity to study PCSK9 protein isoforms at physiologically relevant concentrations.

Journal: Scientific reports

Published: June 05, 2023

Developing Therapeutic Splice-Correcting Antisense Oligomers for Adult-Onset Pompe Disease with c.-32-13T>G Mutation.

Developing Therapeutic Splice-Correcting Antisense Oligomers for Adult-Onset Pompe Disease with c.-32-13T>G Mutation.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 18, 2022

Characterising splicing defects of ABCA4 variants within exons 13-50 in patient-derived fibroblasts.

Characterising splicing defects of ABCA4 variants within exons 13-50 in patient-derived fibroblasts.

Journal: Experimental eye research

Published: May 12, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026